Literature DB >> 2905991

Do nizatidine and cimetidine interact with ibuprofen?

D R Forsyth1, K S Jayasinghe, C J Roberts.   

Abstract

The potential for interaction between ibuprofen and two histamine H2-receptor blocking drugs--nizatidine and cimetidine--was investigated in six healthy male volunteers aged 20 to 25 years. Each subject received placebo, nizatidine 300 mg and cimetidine 800 mg orally at 9.00 p.m. daily for six doses in three randomised treatment periods separated by eight days. On the third day of each treatment period ibuprofen 400 mg was administered at the same time and venous blood samples were taken at intervals throughout the night and subsequently up to 84 h after administration. There was no difference in the area under the plasma concentration-time curve, rate of absorption or half-life of elimination of ibuprofen between the three treatments. The elimination half-life of ibuprofen on placebo was 2.04 h. The elimination half-life of nizatidine on ibuprofen was 1.72 h and that of cimetidine was 3.54 h. The latter is higher than previously reported in normal subjects. It is concluded that neither H2-blocker affects the kinetics of ibuprofen in man.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2905991     DOI: 10.1007/BF00555513

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  25 in total

1.  Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man.

Authors:  W L Burland; W A Duncan; T Hesselbo; J G Mills; P C Sharpe; S J Haggie; J H Wyllie
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

Review 2.  Drug interactions with cimetidine: an update.

Authors:  M C Gerber; G A Tejwani; N Gerber; J R Bianchine
Journal:  Pharmacol Ther       Date:  1985       Impact factor: 12.310

3.  Lack of effect of nizatidine on hepatic drug metabolism in man.

Authors:  J W Secor; K V Speeg; C G Meredith; R F Johnson; P Snowdy; S Schenker
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

4.  The effects of enzyme induction and enzyme inhibition on labetalol pharmacokinetics.

Authors:  T K Daneshmend; C J Roberts
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

5.  Potentially lethal interaction of cimetidine and morphine.

Authors:  A Fine; D N Churchill
Journal:  Can Med Assoc J       Date:  1981-06-01       Impact factor: 8.262

6.  High-pressure liquid chromatographic determination of ibuprofen in plasma.

Authors:  J L Shimek; N G Rao; S K Khalil
Journal:  J Pharm Sci       Date:  1981-05       Impact factor: 3.534

7.  Influence of cimetidine on the disposition of ibuprofen in the rat.

Authors:  K A Parrott; J M Christensen
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1984-03

8.  Determination of ibuprofen in serum by high-performance liquid chromatography and application to ibuprofen disposition.

Authors:  G L Kearns; J T Wilson
Journal:  J Chromatogr       Date:  1981-11-13

9.  Cimetidine-phenytoin interaction: effect on serum phenytoin concentration and antipyrine test.

Authors:  P J Neuvonen; R A Tokola; M Kaste
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

10.  Cimetidine spares the glucuronidation of lorazepam and oxazepam.

Authors:  R V Patwardhan; G W Yarborough; P V Desmond; R F Johnson; S Schenker; K V Speeg
Journal:  Gastroenterology       Date:  1980-11       Impact factor: 22.682

View more
  5 in total

Review 1.  Interactions between non-steroidal anti-inflammatory drugs and H2-receptor antagonists or prostaglandin analogues.

Authors:  J S Dixon; M C Page
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

Review 2.  Pharmacokinetic drug interactions with anti-ulcer drugs.

Authors:  R D Negro
Journal:  Clin Pharmacokinet       Date:  1998-08       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of ibuprofen. The first 30 years.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

Review 4.  Pharmacokinetics of Ibuprofen in children with cystic fibrosis.

Authors:  Emily E Han; Paul M Beringer; Stan G Louie; Mark A Gill; Bertrand J Shapiro
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 5.  Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  J R Brouwers; P A de Smet
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.